Vanessa: It’s the end of an era for the Texas Rangers, but not the end of the conversation. Corey Seager played through a bone spur in his elbow all season long, and now we’re looking at a roster that finished 80-82 but still holds first place in the AL West by virtue of everyone else stumbling harder.
Nick: Right. It’s a weird standing. First in the division, but sitting on the couch for October. The beer stayed on ice, as they say. We’ve got a packed mailbag today to unpack what went wrong, who’s staying, and how we get from 80 wins to those 85-win projections we talked about last week.
Vanessa: Welcome to the Beatline Podcast Network! I’m Vanessa, and this is your daily deep dive into the Texas Rangers. Joining me is our analyst, Nick. Nick, let’s set the scene. You said it yourself—first in the West, no playoffs.
Nick: Yeah, it’s a classic case of winning the right game at the wrong time. They had the best record in the division, but when you look at the final day against Minnesota, that 6-4 loss with Josh Bell’s home run really encapsulates the offensive struggles down the stretch.
Vanessa: So here’s what we’re tackling today. First, we’re answering fan questions about the biggest storyline: Corey Seager’s health and that bone spur revelation. Second, we’re diving into the infield logjam—Justin Foscue, Nicky Lopez, Josh Jung—and who actually starts next year. And third, we’ve got a fun hypothetical about the bullpen and a lightning round of quick takes. Let’s get into the mailbag.
Vanessa: First question comes from Sarah in Arlington. She asks: 'Chris Young mentioned Corey Seager played with a bone spur in his elbow during the second half. How bad was that really affecting his performance, and does it change your 85-win projection for 2027?' Nick, you’ve been tracking this closely.
Nick: It’s significant, Sarah. If he’s playing with a bone spur, that’s not just pain; that’s mechanical limitation. For a shortstop like Seager, whose game relies on quick hands and consistent contact quality, any elbow issue can drop his launch angle or slow his swing speed. That directly impacts OBP and extra-base hits.
Vanessa: So, if he’s fully healthy in spring training, do we go back to that 85-win mark? Because right now, they’re at 80.
Nick: I think so. Five wins isn’t a huge gap, but it’s the difference between a wild card bubble team and a lock. If Seager recovers fully, his presence stabilizes the middle of the lineup. But remember, they also lost that final game to the Twins, which shows the vulnerability when the offense goes cold.
Vanessa: Next up, @RangersFan99 on Twitter asks: 'With Seager potentially needing surgery or rest, where does Ezequiel Duran fit in? Is he the everyday SS if Corey sits out the start of 2027?' This is a huge depth chart question.
Nick: Duran is versatile, sure. He can play SS, 2B, even some corner spots. But defensively, he’s not quite the caliber of Seager yet. If Seager is out, Duran starts, but I’d expect them to be careful with him. Maybe they use Justin Foscue more there too, given his defensive reliability.
Vanessa: That leads perfectly into our next batch of questions about the infield. Marcus in Houston wants to know: 'We have Justin Foscue, Nicky Lopez, Josh Jung, and Cody Freeman. Who gets the starting job at second base in 2027?' We predicted Foscue would take it last episode, but is that still solid?
Nick: It’s still solid. Foscue has shown enough plate discipline and defensive range to earn the spot. Nicky Lopez is more of a contact guy with lower power, which limits his ceiling as an everyday starter unless he finds more pop. Josh Jung is locked in at third, and Cody Freeman is still figuring things out.
Vanessa: Exactly. Foscue provides that balance. But what about the outfield? With Brandon Nimmo in RF and Wyatt Langford in LF, Evan Carter and Cam Cauley are battling for CF. Any insight there from the brief data?
Nick: Carter is the clear favorite based on age and upside. He’s young, he’s athletic, and he fits the profile of a leadoff or top-of-order hitter. Cauley is a backup option, but Carter needs to show consistency in his approach to keep that spot.
Vanessa: Before we move on, I want to ask you something real quick. If these daily breakdowns are part of your morning routine or commute, a small tip is what keeps them coming. Please check the link in the episode description to support us—it helps keep the show free and daily. Thank you.
Vanessa: Alright, Segment Two. Let’s talk roster battles. Jennifer in Dallas asks: 'The pitching staff looks crowded. We have deGrom, Montgomery, Eovaldi, Gore, Rocker, and others. Who is actually locking down the rotation for 2027?' This is a big one.
Nick: It’s crowded, but not all equal. Jacob deGrom and Jordan Montgomery are the anchors if they’re healthy. Nathan Eovaldi provides innings if he stays durable. MacKenzie Gore and Kumar Rocker are the high-upside arms, but Rocker is still developing. It’s going to be a competition.
Vanessa: And the bullpen? We’ve got Tyler Alexander, Robby Ahlstrom, Gavin Collyer, Robert Garcia... it’s a laundry list. What’s the plan there?
Nick: The bullpen is always the wildcard. They need stability. Guys like Jakob Junis and Trevor Williams provide experience, but the younger arms like Peyton Gray and Michel Otanez will likely compete for setup roles. It’s not set in stone yet.
Vanessa: What about the catchers? Elias Diaz, Kyle Higashioka, Danny Jansen. Three veterans. Do they keep all three?
Nick: Probably not all three. Danny Jansen is an elite defender. Elias Diaz offers bat-to-ball skills. Higashioka is a veteran presence. I suspect they’ll keep two starters and a utility catcher, or maybe sign a minor league deal for depth. It’s a decision Chris Young will make in November.
Vanessa: Let’s bring in another listener. @BaseballMike32 asks: 'Logan O’Hoppe and Joc Pederson both DH. Who wins the job?' Simple question, tough answer.
Nick: O’Hoppe is the future. He’s young, he’s hitting well, and he has defensive value behind the plate if needed. Pederson is a platoon specialist with great pull-side power. I think O’Hoppe gets the majority of reps, but Pederson is valuable in lefty-heavy matchups.
Vanessa: Right. O’Hoppe provides versatility. Pederson is specific. That’s a good mix. One more on the infield: 'Josh Jung at third. Is he the long-term answer, or do they look elsewhere?'
Nick: Jung is the answer. He’s proven himself. Cody Freeman is depth, but Jung is the starter. No doubt about it. The key is keeping him healthy.
Vanessa: Okay, Segment Three. Fun hypothetical time. Imagine the Rangers win 85 games in 2027. Corey Seager is back, Foscue is at second, and the rotation is deGrom, Montgomery, and Gore. Who is the MVP of that team?
Nick: I’m going with Evan Carter. If he steps up as the everyday center fielder and contributes offensively, he could be the surprise star. Seager is the engine, but Carter could be the spark.
Vanessa: I love that. Carter, the breakout candidate. Okay, lightning round. Quick takes. First: Did the Rangers miss the playoffs because of bad luck or bad play?
Nick: Bad play in key moments. That loss to the Twins wasn’t luck; it was a failure to score runs against Dean Kremer when it mattered most.
Vanessa: Second: Best player on the current roster?
Nick: Corey Seager, despite the injury. He’s still their best player.
Vanessa: Third: Biggest concern heading into winter meetings?
Nick: Pitching depth. If deGrom or Montgomery get hurt again, who steps up? Rocker isn’t ready yet.
Vanessa: That’s our mailbag. We covered Seager’s elbow, the infield logjam, and the pitching staff. Subscribe, rate, and review us wherever you listen. Go Rangers!